Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc.
XENE
Valuace
70
Růst
0
Zdraví
75
Cena
$ 38.12
Dnes
--0.77 (-1.89%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
2.9B
Obrat
0B
Zisk
0B
Aktiva
1B
Dluh
0B
ROE
-55%
ROA
-50%
PE
-13
PS
581
Cena 1R
27-47
⌀ Cena
36.95
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
26-02-2026
Poslední dividenda

Profil

Xenon Pharmaceuticals Inc., biofarmaceutická společnost v klinickém stadiu, se zabývá vývojem terapeutických prostředků pro léčbu pacientů s neurologickými poruchami v Kanadě. Jeho potrubí klinického vývoje zahrnuje XEN496, A Kv7 kalium channel opener, což je fáze III klinických studií pro léčbu KCNQ2 vývojové a epileptické encefalopatie; a XEN1101, A Kv7 kalium channel opener, který je ve fázi II klinické studie pro léčbu epilepsie a dalších neurologických poruch. Produktově orientovaný modulátor NBI-921352, selektivní inhibitor sodíkových kanálů Nav1.6, který je ve fázi II klinických studií pro léčbu SCN8A vývojové a epileptické encefalopatie a dalších potenciálních indikací, včetně fokální epilepsie dospělých, a XEN007, modulátor vápníkových kanálů působící na centrální nervový systém, který je součástí klinických studií fáze II. Má licenci a smlouvu o spolupráci s Neurocrine Biosciences, Inc. na vývoj léčby epilepsie a s Flexion Therapeutics, Inc. na vývoj PCRX301 (XEN402, inhibitor Nav1.7) pro léčbu pooperační bolesti. Společnost Xenon Pharmaceuticals Inc. byla založena v roce 1996 a sídlí v Burnaby v Kanadě.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
316
Založení
2014-11-05
Adresa
3650 Gilmore Way
CEO
Ian C. Mortimer CPA,

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 202520242023202220212020201920182017201620152014201320122011
Total Revenues7.57.50.00.09.418.432.26.80.00.31.815.628.427.414.36.9
Cost of Revenues78.32.52.6167.50.00.00.00.06.00.00.00.00.00.00.00.0
Gross Profit-70.85.0-2.6-167.59.418.432.26.8-6.00.31.815.628.427.414.36.9
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues0.00.00.07.50.00.00.00.05.40.0
Cost of Revenues0.677.10.60.00.00.00.00.60.91.7
Gross Profit-0.6-77.1-0.67.50.00.00.0-0.64.5-1.7
Operating Income TTM 202520242023202220212020201920182017201620152014201320122011
R&D Expenses0.00.00.0167.5105.875.550.538.823.625.619.815.211.812.310.512.3
Selling General & Admin Expenses0.00.00.046.532.822.012.910.88.47.36.89.85.55.37.06.7
Depreciation & Amortization2.52.52.63.51.60.90.62.80.60.60.91.00.70.70.81.1
Total Operating Expenses302.3378.0276.746.5138.697.463.549.632.032.926.624.917.317.617.519.0
Operating Income-373.1-373.1-279.3-214.1-129.1-79.0-31.3-42.8-38.0-32.6-24.8-9.411.19.7-3.2-12.1
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.00.00.00.00.00.00.00.041.142.9
Selling General & Admin Expenses0.00.00.00.00.00.00.00.011.812.8
Depreciation & Amortization0.60.60.60.70.60.70.60.60.91.7
Total Operating Expenses109.219.393.680.277.573.769.158.452.855.7
Operating Income-109.8-96.3-94.2-72.7-77.5-73.7-69.1-59.0-53.7-55.7
Net Income TTM 202520242023202220212020201920182017201620152014201320122011
Interest Income27.726.841.927.68.70.52.32.41.20.50.50.50.60.30.10.2
Interest Expense0.00.00.00.0-5.50.00.51.41.40.00.00.00.00.10.10.1
Other Expense28.228.240.931.43.90.12.21.23.71.41.3-6.41.32.0-1.20.1
IBT-344.9-344.9-238.4-182.7-125.3-78.9-29.1-41.6-34.5-30.7-23.0-15.813.012.0-4.3-12.0
Income Tax Expense1.01.0-4.10.30.10.0-0.30.04.9-1.9-1.8-1.00.00.10.10.1
Net Income-345.9-345.9-234.3-182.4-125.4-78.9-28.8-41.6-34.5-30.7-23.0-15.813.012.0-4.3-12.0
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income6.26.27.28.19.410.310.811.48.77.0
Interest Expense0.00.00.00.00.00.00.00.07.60.0
Other Expense5.06.18.98.17.910.610.811.58.77.1
IBT-104.7-90.2-85.3-64.6-69.5-63.1-58.3-47.5-44.9-48.6
Income Tax Expense0.50.7-0.60.4-3.8-0.3-0.30.4-0.2-0.2
Net Income-105.3-90.9-84.7-65.0-65.7-62.8-57.9-47.9-44.7-48.5
Per Share Data TTM 202520242023202220212020201920182017201620152014201320122011
EPS$0.00$0.00$0.00$-2.73$-2.07$-1.81$-0.83$-1.60$-1.78$-1.71$-1.48$-1.10$4.11$0.42$-0.47$-1.32
EPS Diluted$0.00$0.00$0.00$-2.73$-2.07$-1.81$-0.83$-1.60$-1.78$-1.71$-1.48$-1.10$3.28$0.39$-0.44$-1.23
Shares Outstanding79.379.377.966.960.543.634.525.919.418.015.514.33.29.19.19.1
Diluted Shares Outstanding79.379.377.966.960.543.634.525.919.418.015.514.34.09.89.89.7
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.64$-0.73
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.64$-0.73
Shares Outstanding79.379.279.078.778.477.977.777.670.066.0
Diluted Shares Outstanding79.379.279.078.778.477.977.777.670.066.0
Current Assets TTM 2024202320222021202020192018201720162015201420132012
Cash And Equivalents136.7142.7148.657.2175.745.024.867.820.517.158.772.038.060.2
Short Term Investments584.8484.2489.4534.8376.1132.0116.651.623.247.10.012.011.30.0
Total Cash & ST Investments721.5626.9638.1592.1551.8177.0141.4119.343.764.158.784.049.360.2
Accounts Receivable0.91.50.91.02.81.80.80.30.40.20.30.20.40.4
Inventory0.00.00.0-1.0-2.8-1.80.00.00.00.0-0.30.00.00.0
Other Current Assets5.76.96.08.27.24.80.01.90.71.32.20.70.20.1
Total Current Assets728.1635.3645.0600.3559.0181.8144.9121.444.865.760.984.949.960.7
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents104.5135.4116.7142.787.6136.758.9148.699.664.6
Short Term Investments357.8352.2433.0484.2566.4584.8640.7489.4427.1475.0
Total Cash & ST Investments462.3487.5549.6626.9654.0721.5699.6638.1526.7539.6
Accounts Receivable0.81.18.61.50.90.90.80.90.82.1
Inventory0.00.00.00.00.00.00.00.0-0.8-2.1
Other Current Assets17.111.67.36.94.75.76.86.03.52.9
Total Current Assets480.1500.3565.5635.3659.6728.1707.2645.0531.0544.6
Long-Term Assets TTM 2024202320222021202020192018201720162015201420132012
Net Property, Plant & Equipment18.718.218.816.912.56.92.61.01.11.42.02.51.92.6
Goodwill0.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Intangible Assets0.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Long-Term Investments129.1127.5292.8128.70.00.00.00.00.00.00.00.00.00.0
Other Long-Term Assets7.47.57.47.80.00.00.00.00.20.41.10.02.70.0
Total Long-Term Assets155.9162.9319.8153.813.07.42.81.01.31.83.12.54.62.6
Total Assets884.0798.1964.8754.1572.0189.2147.7122.446.167.563.987.454.563.3
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment15.816.517.318.218.418.718.318.819.719.4
Goodwill0.00.00.00.00.00.00.00.00.00.0
Intangible Assets0.00.00.00.00.00.00.00.00.00.0
Long-Term Investments93.0137.3141.5127.5149.3129.1185.8292.8112.4112.6
Other Long-Term Assets7.19.28.17.57.57.47.37.427.727.7
Total Long-Term Assets127.7174.0177.7162.9176.3155.9211.8319.8140.1140.3
Total Assets607.8674.3743.3798.1835.9884.0919.0964.8671.1684.9
Current Liabilities TTM 2024202320222021202020192018201720162015201420132012
Accounts Payable9.55.18.68.53.83.02.50.71.31.51.10.60.40.8
Short-Term Debt1.41.41.30.50.60.34.815.00.70.00.00.00.00.0
Other Current Liabilities20.423.517.413.70.67.86.33.52.12.11.52.11.91.4
Current Liabilities31.335.627.322.714.314.843.44.14.13.52.814.318.219.2
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable4.64.86.95.15.49.56.48.66.112.0
Short-Term Debt1.51.51.41.41.41.41.31.31.21.2
Other Current Liabilities32.325.017.223.522.920.414.517.417.414.9
Current Liabilities38.333.032.035.629.731.322.227.324.728.2
Long-Term Liabilities TTM 2024202320222021202020192018201720162015201420132012
Long-Term Debt8.77.69.69.97.73.111.615.06.10.00.00.00.01.7
Capital Leases8.79.010.910.48.33.30.90.00.00.00.00.00.00.0
Def. Tax Liability0.00.00.00.50.00.00.00.00.00.00.00.00.00.0
Total Liabilities40.043.236.932.622.017.855.719.110.23.62.914.630.450.7
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt6.87.37.37.68.48.79.19.69.810.3
Capital Leases0.08.78.79.09.810.09.19.611.011.5
Def. Tax Liability0.00.00.00.00.00.00.00.00.00.0
Total Liabilities48.340.339.343.238.140.031.336.934.538.4
Total Common Equity TTM 2024202320222021202020192018201720162015201420132012
Common Stock1,440.51,456.81,436.41,065.1783.2397.7294.2265.9173.8173.2148.6147.26.16.0
Retained Earnings-771.0-899.5-665.1-482.7-357.4-278.5-249.7-207.9-173.4-142.7-119.7-103.7-116.8-128.8
Comprehensive Income-2.2-1.6-0.1-3.0-1.0-1.0-1.0-1.0-1.0-1.0-1.0-1.02.53.7
Total Common Equity844.0754.9927.9721.5550.0171.492.0103.335.963.961.072.824.112.6
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock1,475.41,469.21,460.91,456.81,441.81,440.51,439.01,436.41,122.01,083.0
Retained Earnings-1,140.1-1,049.2-964.5-899.5-833.8-771.0-713.1-665.1-620.4-571.9
Comprehensive Income0.50.1-0.8-1.61.3-2.2-1.8-0.1-3.0-3.3
Total Common Equity559.5634.0704.0754.9797.8844.0887.7927.9636.6646.5
Other TTM 2024202320222021202020192018201720162015201420132012
Total Debt10.09.010.910.48.33.316.515.06.80.00.00.00.01.7
Book Value844.0754.9927.9721.5550.0171.492.0103.335.963.961.072.824.112.6
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.00.00.00.00.00.00.00.00.00.0
Book Value559.5634.0704.0754.9797.8844.0887.7927.9636.6646.5
Cash Flow From Operating Activities TTM 202520242023202220212020201920182017201620152014201320122011
Net Income-199.1-345.9-234.3-182.4-125.4-78.9-28.8-41.6-34.5-30.7-23.0-15.813.012.0-4.3-12.0
Depreciation & Amortization3.82.52.63.51.60.90.60.40.60.60.91.00.70.70.81.1
Stock-Based Compensation42.053.750.732.420.410.05.72.92.62.22.23.70.80.60.40.4
Change Working Capital0.54.45.75.6-0.7-2.6-26.133.50.00.61.8-14.0-14.3-16.747.4-3.3
Change In Accounts Receivable-0.10.1-0.60.11.8-0.5-1.0-0.70.2-0.20.1-0.10.2-0.111.2-11.0
Change In Accounts Payable3.05.58.53.98.13.02.04.50.80.00.50.00.50.00.00.0
Change In Inventories5.60.00.00.00.0-3.0-2.0-4.5-0.80.60.60.0-0.60.00.00.0
Other Non-cash Items24.29.42.8-4.25.71.00.80.2-4.10.0-0.1-0.1-0.1-0.10.30.1
Cash from Operations-151.20.00.0-145.3-98.4-69.5-48.1-4.6-34.7-28.7-19.6-18.10.3-3.345.6-13.7
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income-105.3-90.9-84.7-65.0-65.7-62.8-57.9-47.9-44.7-48.5
Depreciation & Amortization0.60.60.60.70.60.70.70.60.91.7
Stock-Based Compensation14.113.713.712.213.613.014.79.49.28.7
Change Working Capital9.0-0.32.6-12.22.2-0.30.9-5.9-0.6-3.3
Change In Accounts Receivable-0.60.37.6-7.2-0.5-0.10.00.0-0.30.2
Change In Accounts Payable3.20.00.9-3.80.00.00.00.02.3-3.4
Change In Inventories0.00.00.00.00.00.00.00.02.23.4
Other Non-cash Items1.15.13.74.03.50.19.3-2.71.8-0.8
Cash from Operations0.00.00.00.00.00.00.00.0-33.7-42.2
Cash Flow From Investing Activities TTM 202520242023202220212020201920182017201620152014201320122011
Capital Expenditure-2.9-0.8-3.1-5.6-2.9-2.1-2.6-1.2-0.5-0.3-0.3-0.6-1.5-0.2-0.5-0.3
Acquisitions187.10.00.00.0296.0-144.8-214.7-75.4-48.5-52.60.00.0-13.50.00.00.0
Investments-814.1-355.7-532.3-793.9-551.1-389.5-228.9-140.5-77.0-28.0-47.60.0-15.3-17.90.00.0
Sales of Investment689.9574.5700.3682.4258.0144.8214.775.448.552.60.010.713.56.61.014.2
Other Investing Activities-56.30.00.00.0-296.0144.8214.775.448.552.60.00.013.50.00.00.0
Cash from Investing-127.10.00.0-117.2-296.0-246.8-16.8-66.3-29.024.3-47.810.2-3.2-11.50.513.9
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure-0.3-0.3-0.20.0-0.8-0.6-1.5-0.20.0-1.2
Acquisitions0.00.00.00.00.00.00.00.0236.4-49.2
Investments-60.90.0-88.8-131.2-66.4-164.1-125.0-176.8-367.6-146.8
Sales of Investment337.00.0171.2165.8165.6165.2237.2133.8128.5196.0
Other Investing Activities0.00.00.00.00.00.00.00.0-236.449.2
Cash from Investing0.00.00.00.00.00.00.00.0-239.248.0
Cash Flow From Financing Activities TTM 202520242023202220212020201920182017201620152014201320122011
Debt Repaid0.00.00.00.00.00.0-16.70.00.00.00.00.00.00.00.00.0
Debt Issued-1.59.0-1.90.52.24.93.61.48.26.80.00.00.0-1.71.70.0
Issuance of Common Stock350.20.00.0353.5277.8447.3102.527.4102.90.223.80.342.70.00.00.0
Repurchase of Common Stock0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Other Financing Activities383.00.00.00.00.70.30.10.18.76.90.10.0-1.5-4.40.00.0
Cash from Financing350.20.00.0353.5278.5447.585.827.5111.67.124.00.341.1-4.40.00.0
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.00.00.00.00.00.00.00.00.00.0
Debt Issued8.3-0.40.0-0.3-0.8-0.2-0.4-0.5-0.1-0.5
Issuance of Common Stock0.00.00.00.00.00.00.00.0324.029.5
Repurchase of Common Stock0.00.00.00.00.00.00.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.0
Other Financing Activities0.00.00.00.00.00.00.00.00.00.0
Cash from Financing0.00.00.00.00.00.00.00.0320.729.5
Cash position TTM 202520242023202220212020201920182017201620152014201320122011
Net Change in Cash72.256.5-5.991.4-118.4130.720.3-43.047.33.4-41.6-13.434.1-22.246.2-0.1
Closing Cash Balance136.7199.2142.7148.657.2175.745.024.867.820.517.158.772.038.060.213.9
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash94.6-30.918.7-26.155.1-49.177.8-89.749.135.0
Closing Cash Balance199.2104.5135.4116.7142.787.6136.758.9148.699.6
Free Cash Flow TTM 202520242023202220212020201920182017201620152014201320122011
Free Cash Flow-154.1-279.9-184.5-150.9-101.3-71.6-50.8-5.9-35.2-29.0-19.8-18.7-1.3-3.545.0-14.0
Real Free Cash Flow-196.2-333.6-235.2-183.3-121.7-81.6-56.4-8.8-37.9-31.3-22.0-22.4-2.0-4.144.6-14.4
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow-81.8-72.0-64.4-61.7-55.2-50.3-34.2-46.4-33.7-43.4
Real Free Cash Flow-95.9-85.7-78.1-73.9-68.8-63.3-48.9-55.8-42.9-52.2
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E-12.6-9.1-1.4
P/S580.62729.89.4
P/B7.835.2
P/FCF-13.1-18.1-1.5
Market cap$2.9$23.0
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets1.4 %3.4 %0 %
Debt to Income-2.4 %-10.7 %0 %
Debt to Free cash flow-2.5 %-892.5 %0 %
Interest expense percentage0 %-0.7 %44.7 %
Current ratio12.5 19.1 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE-61.8 %-24 %0 %
ROA-56.9 %-21.8 %0 %
CapEx to Revenue16.9 %1916.7 %0 %
RaD to Revenue0 %45259.8 %0 %
ROEM22,935.8 112135.4

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin-935.8 %-1356.3 %68.7 %
Operating margin-4543.7 %-58262.6 %35.5 %
Net margin-4084.5 %-50428.6 %9.5 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0 %0 %
Dividend payout percentage0 %0 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding79.2 mil 35.9 mil
Employee count0.3 tis 0.1 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader